Trial Profile
Alopecia Prevention Trial of Topical Vasoconstrictor Therapy in Head and Neck Cancer Patients Treated With Intensity Modulated Radiotherapy (IMRT)
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 May 2014
Price :
$35
*
At a glance
- Drugs Norepinephrine (Primary)
- Indications Alopecia
- Focus Adverse reactions
- Sponsors ProCertus BioPharm
- 13 May 2014 New trial record